134 related articles for article (PubMed ID: 35688521)
1. Regional Nodal Management After Preoperative Systemic Therapy.
Singer L; Weiss A; Bellon JR; King TA
Semin Radiat Oncol; 2022 Jul; 32(3):228-236. PubMed ID: 35688521
[TBL] [Abstract][Full Text] [Related]
2. Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial.
Boughey JC; McCall LM; Ballman KV; Mittendorf EA; Ahrendt GM; Wilke LG; Taback B; Leitch AM; Flippo-Morton T; Hunt KK
Ann Surg; 2014 Oct; 260(4):608-14; discussion 614-6. PubMed ID: 25203877
[TBL] [Abstract][Full Text] [Related]
3. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy.
Kuerer HM; Sahin AA; Hunt KK; Newman LA; Breslin TM; Ames FC; Ross MI; Buzdar AU; Hortobagyi GN; Singletary SE
Ann Surg; 1999 Jul; 230(1):72-8. PubMed ID: 10400039
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer subtypes affect the nodal response after neoadjuvant chemotherapy in locally advanced breast cancer: Are we ready to endorse axillary conservation?
Cerbelli B; Botticelli A; Pisano A; Campagna D; De Vincentiis L; Pernazza A; Frusone F; Scavina P; Monti M; Fortunato L; Costarelli L; d'Amati G
Breast J; 2019 Mar; 25(2):273-277. PubMed ID: 30734420
[TBL] [Abstract][Full Text] [Related]
5. Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery.
Tadros AB; Yang WT; Krishnamurthy S; Rauch GM; Smith BD; Valero V; Black DM; Lucci A; Caudle AS; DeSnyder SM; Teshome M; Barcenas CH; Miggins M; Adrada BE; Moseley T; Hwang RF; Hunt KK; Kuerer HM
JAMA Surg; 2017 Jul; 152(7):665-670. PubMed ID: 28423171
[TBL] [Abstract][Full Text] [Related]
6. Conservative surgery after neoadjuvant chemotherapy in patients with operable breast cancer.
Franceschini G; Di Leone A; Natale M; Sanchez MA; Masett R
Ann Ital Chir; 2018; 89():290. PubMed ID: 30352955
[TBL] [Abstract][Full Text] [Related]
7. Local and regional therapy considerations after preoperative therapy in patients with breast cancer.
Untch M
Curr Opin Obstet Gynecol; 2021 Feb; 33(1):59-63. PubMed ID: 33122576
[TBL] [Abstract][Full Text] [Related]
8. Assessing the impact of neoadjuvant chemotherapy on the management of the breast and axilla in breast cancer.
McVeigh TP; Al-Azawi D; Kearney DE; Malone C; Sweeney KJ; Barry K; McLaughlin R; Keane M; Kerin MJ
Clin Breast Cancer; 2014 Feb; 14(1):20-5. PubMed ID: 24157259
[TBL] [Abstract][Full Text] [Related]
9. Patterns of axillary staging and management in clinically node positive breast cancer patients treated with neoadjuvant systemic therapy: Results of a survey amongst breast cancer specialists.
Simons JM; Maaskant-Braat AJG; Luiten EJT; Leidenius MHK; van Nijnatten TJA; Boelens PG; Koppert LB; van der Pol CC; van de Velde CJH; Audisio RA; Smidt ML
Eur J Surg Oncol; 2020 Jan; 46(1):53-58. PubMed ID: 31434617
[TBL] [Abstract][Full Text] [Related]
10. The Evolving and Multidisciplinary Considerations in Nodal Radiation in Breast Cancer.
Gerber NK; Port E; Chadha M
Semin Radiat Oncol; 2019 Apr; 29(2):150-157. PubMed ID: 30827453
[TBL] [Abstract][Full Text] [Related]
11. Management of early stage HER2 positive breast cancer and increased implementation of axillary imaging to improve identification of nodal metastasis.
McCaffrey RL; Thompson JL; Oudsema RH; Sciallis AP; Cobain EF; Sabel MS; Jeruss JS
J Surg Oncol; 2022 Jun; 125(8):1218-1223. PubMed ID: 35230701
[TBL] [Abstract][Full Text] [Related]
12. Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab.
Hsiang DJ; Yamamoto M; Mehta RS; Su MY; Baick CH; Lane KT; Butler JA
Arch Surg; 2007 Sep; 142(9):855-61; discussion 860-1. PubMed ID: 17875840
[TBL] [Abstract][Full Text] [Related]
13. Axillary staging prior to neoadjuvant chemotherapy: the roles of sentinel lymph node biopsy and axillary ultrasonography.
Lee MC; Joh JE; Chau A
Cancer Control; 2012 Oct; 19(4):277-85. PubMed ID: 23037495
[TBL] [Abstract][Full Text] [Related]
14. Sentinel node biopsy before neoadjuvant chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancer.
Cox CE; Cox JM; White LB; Stowell NG; Clark JD; Allred N; Meyers M; Dupont E; Furman B; Minton S
Ann Surg Oncol; 2006 Apr; 13(4):483-90. PubMed ID: 16523361
[TBL] [Abstract][Full Text] [Related]
15. Management of the axilla after neo-adjuvant chemotherapy for breast cancer: Sentinel node biopsy and radiotherapy considerations.
Currey A; Patten CR; Bergom C; Wilson JF; Kong AL
Breast J; 2018 Nov; 24(6):902-910. PubMed ID: 30255534
[TBL] [Abstract][Full Text] [Related]
16. Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With an Initial Diagnosis of Cytology-Proven Lymph Node-Positive Breast Cancer.
Enokido K; Watanabe C; Nakamura S; Ogiya A; Osako T; Akiyama F; Yoshimura A; Iwata H; Ohno S; Kojima Y; Tsugawa K; Motomura K; Hayashi N; Yamauchi H; Sato N
Clin Breast Cancer; 2016 Aug; 16(4):299-304. PubMed ID: 26993216
[TBL] [Abstract][Full Text] [Related]
17. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy.
Kuerer HM; Newman LA; Smith TL; Ames FC; Hunt KK; Dhingra K; Theriault RL; Singh G; Binkley SM; Sneige N; Buchholz TA; Ross MI; McNeese MD; Buzdar AU; Hortobagyi GN; Singletary SE
J Clin Oncol; 1999 Feb; 17(2):460-9. PubMed ID: 10080586
[TBL] [Abstract][Full Text] [Related]
18. [Axillary pathologic response after neoadjuvant chemotherapy in locally advanced breast cancer with axillary involvement].
Jiménez-Ballvé A; Serrano-Palacio A; García-Sáenz JA; Ortega Candil A; Salsidua-Arroyo O; Román-Santamaría JM; Pelayo Alarcón A; Fuentes Ferrer ME; Carreras-Delgado JL
Rev Esp Med Nucl Imagen Mol; 2015; 34(4):230-5. PubMed ID: 25743035
[TBL] [Abstract][Full Text] [Related]
19. Breast MRI and tumour biology predict axillary lymph node response to neoadjuvant chemotherapy for breast cancer.
Al-Hattali S; Vinnicombe SJ; Gowdh NM; Evans A; Armstrong S; Adamson D; Purdie CA; Macaskill EJ
Cancer Imaging; 2019 Dec; 19(1):91. PubMed ID: 31878958
[TBL] [Abstract][Full Text] [Related]
20. Axillary Ultrasound Identifies Residual Nodal Disease After Chemotherapy: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance).
Le-Petross HT; McCall LM; Hunt KK; Mittendorf EA; Ahrendt GM; Wilke LG; Ballman KV; Boughey JC
AJR Am J Roentgenol; 2018 Mar; 210(3):669-676. PubMed ID: 29381381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
